Essential Hypertension
|
0.030 |
Biomarker
|
disease |
BEFREE |
1 Urotensin-II (U-II) is among the most potent mammalian vasoconstrictors identified and may play a role in the aetiology of essential hypertension.
|
12770952 |
2003 |
Adrenal Cortical Adenoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Urotensin II-like immunoreactivity was detected in one of eight adrenocortical adenomas, two of four adrenocortical carcinomas, one of six pheochromocytomas, and one of five neuroblastomas by radioimmunoassay, but not in normal portions of adrenal glands (detection limit; 0.2pmol/g wet weight).
|
12668216 |
2003 |
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
U-II is also a neuropeptide and may play a role in tumour development.
|
15883758 |
2005 |
Hypertensive disease
|
0.580 |
Biomarker
|
group |
CTD_human |
Urotensin-II (U-II) receptors are widely distributed in the central nervous system.Intracerebroventricular (i.c.v.) injection of U-II causes hypertension and bradycardia and stimulates prolactin and thyrotropin secretion.
|
16160878 |
2005 |
Bradycardia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Urotensin-II (U-II) receptors are widely distributed in the central nervous system.Intracerebroventricular (i.c.v.) injection of U-II causes hypertension and bradycardia and stimulates prolactin and thyrotropin secretion.
|
16160878 |
2005 |
Kidney Failure
|
0.040 |
Biomarker
|
disease |
BEFREE |
UII may also play a role in renal disease, being elevated in the circulation or urine of patients with renal failure and in experimental models of cardiovascular disease such as the spontaneously hypertensive rat.
|
16807543 |
2006 |
Cardiovascular Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
UII may also play a role in renal disease, being elevated in the circulation or urine of patients with renal failure and in experimental models of cardiovascular disease such as the spontaneously hypertensive rat.
|
16807543 |
2006 |
Cardiovascular Diseases
|
0.100 |
Biomarker
|
group |
LHGDN |
UII may also play a role in renal disease, being elevated in the circulation or urine of patients with renal failure and in experimental models of cardiovascular disease such as the spontaneously hypertensive rat.
|
16807543 |
2006 |
Conn Adenoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Urotensin II was more expressed in pheochromocytoma than in aldosterone-producing adenoma tissue; the opposite was seen for the urotensin II receptor expression.
|
19001524 |
2009 |
Pheochromocytoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Urotensin II is a putative mediator of the effects of the adrenal medulla and pheochromocytoma on the adrenocortical zona glomerulosa.
|
19001524 |
2009 |
Adrenal Gland Pheochromocytoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Urotensin II is a putative mediator of the effects of the adrenal medulla and pheochromocytoma on the adrenocortical zona glomerulosa.
|
19001524 |
2009 |
Cardiovascular Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Urotensin II (UII) and its receptor UT are upregulated in the pathological setting of various cardiovascular diseases including atherosclerosis.
|
19111831 |
2009 |
Arteriosclerosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Urotensin II (UII) and its receptor UT are upregulated in the pathological setting of various cardiovascular diseases including atherosclerosis.
|
19111831 |
2009 |
Atherosclerosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Urotensin II (UII) and its receptor UT are upregulated in the pathological setting of various cardiovascular diseases including atherosclerosis.
|
19111831 |
2009 |
Heart failure
|
0.060 |
Biomarker
|
disease |
BEFREE |
Urotensin II (UII) and its receptor UT are involved in control of the cardiovascular system and are implicated in heart failure.
|
19258379 |
2009 |
Congestive heart failure
|
0.060 |
Biomarker
|
disease |
BEFREE |
Urotensin II (UII) and its receptor UT are involved in control of the cardiovascular system and are implicated in heart failure.
|
19258379 |
2009 |
Fibrosis, Liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
Urotensin II (UII) and its receptor (UT or GPR14) are involved in liver fibrosis and portal hypertension.
|
20428787 |
2010 |
Hepatitis B
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
UII and UT gene expression were quantified in liver biopsy samples from patients with hepatitis-B-virus-associated cirrhosis and portal hypertension, and from normal controls by using quantitative real-time PCR.
|
20428787 |
2010 |
Liver Cirrhosis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
UII and UT gene expression were quantified in liver biopsy samples from patients with hepatitis-B-virus-associated cirrhosis and portal hypertension, and from normal controls by using quantitative real-time PCR.
|
20428787 |
2010 |
Cirrhosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
UII and UT gene expression were quantified in liver biopsy samples from patients with hepatitis-B-virus-associated cirrhosis and portal hypertension, and from normal controls by using quantitative real-time PCR.
|
20428787 |
2010 |
Portal Hypertension
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
UII and UT gene expression were quantified in liver biopsy samples from patients with hepatitis-B-virus-associated cirrhosis and portal hypertension, and from normal controls by using quantitative real-time PCR.
|
20428787 |
2010 |
Autoimmune Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Urotensin II (UTS-II) is predominantly a vasoactive peptide and Thr21Met polymorphism in UTS-II gene was proved to increasing in some autoimmune diseases.
|
23333481 |
2013 |
Cardiac fibrosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Urotensin II (U-II/UTS2) induces cardiac fibrosis by increasing fibroblast collagen synthesis and increased U-II plasma levels have been reported in patients with atrial fibrosis.
|
26811505 |
2016 |
Diabetic Nephropathy
|
0.220 |
Biomarker
|
disease |
BEFREE |
Urotensin II (UII) and autophagy have been considered as important components in the pathogenesis of diabetic nephropathy.
|
27459313 |
2017 |
Heart failure
|
0.060 |
Biomarker
|
disease |
BEFREE |
Urotensin II and its receptor are thought to be involved in various cardiovascular diseases such as heart failure, pulmonary hypertension and atherosclerosis.
|
28163023 |
2017 |